Back to Article List

Guidance on Protein Quality Studies for Infant Formula

USA

Feb 17, 2023

The U.S. Food and Drug Administration (FDA) has issued draft guidance to manufacturers of infant formula and laboratories conducting testing on infant formula to help them in the design, conduct, evaluation, and reporting of Protein Efficiency Ratio (PER) rat bioassay studies.  Sufficient biological quality of protein is one of many factors FDA considers in evaluating a new infant formula submission. Protein quality is important as infant formula is often a sole source of nutrition, including protein, for infants.

 

For further information (in English), click on the Link

Check the full text of the documents (in English), click on the  Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox